维普中文期刊产品整合服务
25篇 您的检索式:作者名="DIRIX G"
    题名 作者 年代 出处 被引量
1High activity and tolerability demonstrated for exemestane in postmenopausal women with metastatic breast cancer who had previously failed on tamoxifen treatment显示文摘Kvinnsland S Anker G Dirix LY 2000Eur J Cancer2000,36,8:1
2High activity and tolerability demonstrated for exemestane in postmenopausal women with metastatic breast cancer whohad previously failed on tamoxifen treatment 显示文摘Kvinnsland S Anker G Dirix LY 2000Eur J Cancer2000,36,8:1
3High activity and tolerability demonstrated for exemestane in postmenopausal women with metastatic breast cancer who had previously failed on tamoxifen treatment显示文摘Kvinnsland S Anker G Dirix LY 2000Eur J Cancer2000,36,8:1
4Peptide Signal Molecules and Bacteriocins in Gram-negative Bacteria: a Genome- wide in Silico Screening for Peptides Containing a Double-glycine Leader Sequence and Their Cognate Transporters 显示文摘DIRIX G MONSIEURS P DOMBRECHT B 2004Peptides2004,25,:1
5Screening Genomes of Gram-positive Bacteria for Double-glycine-motifcon- raining Peptides 显示文摘DIRIX G MONSIEURS P MARCHAL K 2004Microbiology2004,150,5:1
6Mature results of a randomized phase II postmenopausal women with metastatic breast cancer 显示文摘Atalay G Dirix L Lohrisch C 2003Ann Oncol2003,,9:1
7The effect of exemestane on ser-um lipid rofile in postmenopausal women with metastatic breast canc-er:a companion study to EORTC Trial 10951,'Randomized phaseⅡ study in first line hormonal treatment for metastatic breast cancer with exemestane or tamoxifen in postmenopausal patients'显示文摘Malay G Dirix L Biganzoli L 2004Ann Oncol2004,15,2:1
8Trans fatty acids and birth outcome: some first results of the MEFAB and ABCD cohorts显示文摘HORNSTRA G van EIJSDEN M DIRIX C 2006Atherosclerosis Supplements2006,7,2:1
9High activity and tolerability demonstrated for exemestane in postmenopausal women with metastatic breast cancer who had previously failed on tamoxifen treatment显示文摘Kvinnsland S Anker G Dirix LY 2000Cur J Cancer2000,36,8:1
10High activity and tolerability demonstrated for exemestane in postmenopausal Women with metastatic breast cancerwho had p reviously failed on tamoxifen treatment显示文摘Kvinnsland S Anker G Dirix LY 2000Eur J Cancer2000,36,8:1
11Serum basic fibroblast g rowth factor and vascular endothelial growth factor and tumor growth kinetics in advanced colorectal cancer显示文摘 Vermeulen PB Hubens G 1996Ann Oncol1996,7,:1
12High activity and tolerability de monstrated for exemestane in postmenopausal women with metastatic breast cancer who had previously failed on tamoxifen treatment显示文摘Kvinnsland S Anker G Dirix LY 2000Eur J Cancer2000,36,:1
13High activity and tolerability demonstrated for exemestane in postmenopausal women with metastatic breast cancer who had previously failed on tarnoxifen treatment 显示文摘Kvinnsland S Anker G Dirix LY 2000Eur J Cancer2000,36,:1
14High activity and tolerability demonstrated for exemestane in postmenopausal women with metastatic breast cancer who had previously failed on tamoxifen treatment显示文摘Kvinnsland S Anker G Dirix LY 2000Eur J Cancer2000,36,8:1
15Mature results of a randomized phase Ⅱ postmenopausal women with metasatie breast cancer 显示文摘Atalay G Dirix L Lohrisch C 2003Ann Oncol2003,14,:1
16Serum basic fibroblast growth factor and vascular endothelial growth factor and tumor growth kinetics in advanced colorectal cancer显示文摘Dirix LY Vermeulen PB Hubens G 1996Ann Oncol1996,7,:1
17Trans fatty acids and birth outcome: some fist results of the MEFAB and ABCD cohorts 显示文摘HORNSTRA G Van EIJSDEN M DIRIX C 2006Atheroscler Suppl2006,7,2:1
18High activity and tolerability demonstrated for exemestane in post-menopausal women with metastatic breast cancer who had previously failed on tamoxifen treatment显示文摘Kvinnsland S Anker G Dirix LY 2000Eur J Cancer2000,36,8:1
19Peptide signal molecules and bacteriocins in Gram-negative bacteria: a genome-wide in silico screening for peptides containing a double-glycine leader sequence and their cognate transporters显示文摘Dirix G Monsieurs P Dombrecht B 2004Peptides2004,25,:1
20The efect of exemestane on serum lipid profile in postmenopausal women with metastatic breast cancer: a companion study to EORTC Trial 10951 , 'Randomized phase 1' study in first line hormonal treatment for metastatic breast cancer with exemestane or tamoxifen in postmenopausal patients' 显示文摘Atalay G Dirix L Biganzoli L 2004Ann Oncol2004,15,2:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费